BMO Earns Analyst Buy Rating Ahead of Q2 Results, But Mixed Consensus and Asset Sale Risks Loom
Canaccord Genuity maintains Buy on BMO ahead of May 27 earnings. Shares are up 23.5% YTD near a 52-week high, but analyst consensus is split. A C$14.5B asset sale to Stonepeak aims to boost CET1 ratio but incurs a C$900M charge.
Earnings
